Your browser doesn't support javascript.
loading
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.
Reinartz, Gabriele; Molavi Tabrizi, Caroline; Liersch, Ruediger; Ullerich, Hansjoerg; Hering, Dominik; Willborn, Kay; Schultze, Juergen; Micke, Oliver; Ruebe, Christian; Fischbach, Wolfgang; Bentz, Martin; Daum, Severin; Pott, Christiane; Tiemann, Markus; Moeller, Peter; Neubauer, Andreas; Wilhelm, Martin; Lenz, Georg; Berdel, Wolfgang E; Willich, Normann; Eich, Hans T.
Affiliation
  • Reinartz G; Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany.
  • Molavi Tabrizi C; Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany.
  • Liersch R; Department of Medicine A (Hematology, Oncology, and Pneumology), University Hospital of Muenster, Muenster, Germany.
  • Ullerich H; Department of Medicine B (Gastroenterology and Hepatology), University Hospital of Muenster, Muenster, Germany.
  • Hering D; Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany.
  • Willborn K; Department of Radiotherapy and Radiation Oncology, Pius Hospital Oldenburg, Oldenburg, Germany.
  • Schultze J; Department of Radiation Oncology, University of Schleswig-Holstein, Kiel, Germany.
  • Micke O; Department of Radiotherapy and Radiation Oncology, Franziskus Hospital Bielefeld, Bielefeld, Germany.
  • Ruebe C; Department of Radiation Oncology, University of Saarland, Homburg, Germany.
  • Fischbach W; Department of Gastroenterology and Oncology, Hospital of Aschaffenburg, Aschaffenburg, Germany.
  • Bentz M; Department of Medical Oncology, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
  • Daum S; Department of Gastroenterology, University Charité, Berlin, Germany.
  • Pott C; Department of Medical Oncology, University of Schleswig-Holstein, Kiel, Germany.
  • Tiemann M; Institute for Hematopathology Hamburg, Hamburg, Germany.
  • Moeller P; Department of Pathology, University of Ulm, Ulm, Germany.
  • Neubauer A; Department of Medical Oncology, University of Marburg, Marburg, Germany.
  • Wilhelm M; Department of Medical Oncology, Paracelsus Medical University, Klinikum Nuernberg, Germany.
  • Lenz G; Department of Medicine A (Hematology, Oncology, and Pneumology), University Hospital of Muenster, Muenster, Germany.
  • Berdel WE; Department of Medicine A (Hematology, Oncology, and Pneumology), University Hospital of Muenster, Muenster, Germany.
  • Willich N; Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany.
  • Eich HT; Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany.
Oncologist ; 25(5): e816-e832, 2020 05.
Article in En | MEDLINE | ID: mdl-32219909
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido